2 completed, 1 recruiting, 1 withdrawn. 3 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Carbidopa Levodopa: new trials by email Literature Review of Carbidopa Levodopa trials Research Report on Carbidopa Levodopa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dopaminergic Therapy for Anhedonia - 2 Carbidopa Levodopa, Placebo - Anhedonia, Depression | Phase 4 | Recruiting | Emory University | 70 | 2023-11-21 | 2026-01-28 |
| Research on Translational Outcomes of Alcohol (Project RETRO) Carbidopa Levodopa, Placebo - Alcohol Drinking | Phase 4 | Withdrawn | University of Washington | 2023-02-01 | 2023-02-13 | |
| DTA (Dopaminergic Therapy for Anhedonia) Study Carbidopa Levodopa, Placebo - Depression, Anhedonia | Phase 4 | Completed | Emory University | 19 | 2021-01-29 | 2024-12-16 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa. Opicapone, Carbidopa Levodopa - Parkinson Disease | Phase 1 | Completed | Neurocrine Biosciences | 16 | 2018-02-08 | 2019-03-22 |
Anhedonia (2) · Depression (2) · Alcohol Drinking (1) · Parkinson Disease (1)
Emory University (2) · Neurocrine Biosciences (1) · University of Washington (1)
United States (3)
Jennifer Felger, PhD (2) · Brittney Hultgren, PhD (1)
R33MH121625 (1), R61MH121625 (1)